tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MEDGF Stock Latest News

Medacta Delivers 18.5% Constant-Currency Revenue Growth in 2025 on Broad-Based Demand
Company AnnouncementsMedacta Delivers 18.5% Constant-Currency Revenue Growth in 2025 on Broad-Based Demand
18d ago
Medacta Group price target raised to CHF 182 from CHF 175 at Berenberg
PremiumThe Fly
Medacta Group price target raised to CHF 182 from CHF 175 at Berenberg
28d ago
Medacta’s MPACT DM Cup Study: A Potential Game-Changer in Hip Arthroplasty
PremiumCompany Announcements
Medacta’s MPACT DM Cup Study: A Potential Game-Changer in Hip Arthroplasty
4M ago
MEDGF
Medacta’s GMK SpheriKA Study: A Potential Game-Changer in Knee Prosthesis
PremiumCompany Announcements
Medacta’s GMK SpheriKA Study: A Potential Game-Changer in Knee Prosthesis
4M ago
MEDGF
Medacta’s SMS Femoral Stem Study: A Closer Look at Market Implications
PremiumCompany Announcements
Medacta’s SMS Femoral Stem Study: A Closer Look at Market Implications
4M ago
MEDGF
Medacta’s NextAR System: A Game Changer in Knee Arthroplasty?
PremiumCompany AnnouncementsMedacta’s NextAR System: A Game Changer in Knee Arthroplasty?
4M ago
MEDGF
Medacta’s Shoulder System Study: A Potential Game-Changer for Shoulder Treatments
Premium
Company Announcements
Medacta’s Shoulder System Study: A Potential Game-Changer for Shoulder Treatments
4M ago
MEDGF
Medacta’s ROMAX Hip Resurfacing Study: A Potential Game-Changer for Orthopedic Market
Premium
Company Announcements
Medacta’s ROMAX Hip Resurfacing Study: A Potential Game-Changer for Orthopedic Market
4M ago
MEDGF
Medacta’s Innovative Shoulder System Trial: A Potential Game-Changer in Arthroplasty
PremiumCompany Announcements
Medacta’s Innovative Shoulder System Trial: A Potential Game-Changer in Arthroplasty
4M ago
MEDGF
Medacta’s Innovative Hydrogel Coating: A Game-Changer for Joint Arthroplasty?
PremiumCompany Announcements
Medacta’s Innovative Hydrogel Coating: A Game-Changer for Joint Arthroplasty?
4M ago
MEDGF
Medacta’s Innovative Hip Implant Study: A Potential Game-Changer in Orthopedics
PremiumCompany Announcements
Medacta’s Innovative Hip Implant Study: A Potential Game-Changer in Orthopedics
4M ago
MEDGF
Medacta Group price target raised to CHF 175 from CHF 160 at Berenberg
PremiumThe Fly
Medacta Group price target raised to CHF 175 from CHF 160 at Berenberg
5M ago
Medacta Group price target raised to CHF 161 from CHF 159 at Morgan Stanley
PremiumThe FlyMedacta Group price target raised to CHF 161 from CHF 159 at Morgan Stanley
5M ago
Medacta Group SA Reports Strong Growth in H1 2025
Premium
Company Announcements
Medacta Group SA Reports Strong Growth in H1 2025
5M ago
Medacta Group SA Reports Robust H1 2025 Earnings
Premium
Company Announcements
Medacta Group SA Reports Robust H1 2025 Earnings
5M ago
Medacta Group SA Reports Strong H1 2025 Results with 19.8% Revenue Growth
PremiumCompany Announcements
Medacta Group SA Reports Strong H1 2025 Results with 19.8% Revenue Growth
6M ago
Medacta Group downgraded to Neutral from Buy at UBS
PremiumThe Fly
Medacta Group downgraded to Neutral from Buy at UBS
7M ago
Medacta Group price target raised to CHF 159 from CHF 146 at Morgan Stanley
PremiumThe Fly
Medacta Group price target raised to CHF 159 from CHF 146 at Morgan Stanley
7M ago
Medacta Group SA Reports Strong H1 2025 Revenue Growth and Upgrades Guidance
PremiumCompany Announcements
Medacta Group SA Reports Strong H1 2025 Revenue Growth and Upgrades Guidance
7M ago
Medacta Group SA Approves Board Proposals and Financial Strategies at AGM
PremiumCompany AnnouncementsMedacta Group SA Approves Board Proposals and Financial Strategies at AGM
10M ago
Medacta Announces 2025 AGM Details and Key Proposals
Premium
Company Announcements
Medacta Announces 2025 AGM Details and Key Proposals
11M ago
Medacta Group SA (MEDGF) Reveals Q2 Dividend: Here’s the Essential Information
Premium
Dividends
Medacta Group SA (MEDGF) Reveals Q2 Dividend: Here’s the Essential Information
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >